{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:14:10Z","timestamp":1788786850711,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.etap.2023.104343","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T23:45:17Z","timestamp":1702943117000},"page":"104343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pharmacokinetic characterisation of a valproate Autism Spectrum Disorder rat model in a context of co-exposure to \u03b1-Hexabromocyclododecane"],"prefix":"10.1016","volume":"105","author":[{"given":"C.","family":"Morel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Emond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Debaugnies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Creta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Montagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Borde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Van","family":"Nieuwenhuyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Duca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Grova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.etap.2023.104343_bib1","series-title":"Valproate","first-page":"47","article-title":"Chemistry and biotransformation","author":"Abbott","year":"1999"},{"key":"10.1016\/j.etap.2023.104343_bib2","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1021\/es404644s","article-title":"Enantioselective biotransformation of hexabromocyclododecane by in vitro rat and trout hepatic sub-cellular fractions","volume":"48","author":"Abdallah","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.etap.2023.104343_bib3","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00216-015-8466-z","article-title":"High-resolution mass spectrometry provides novel insights into products of human metabolism of organophosphate and brominated flame retardants","volume":"407","author":"Abdallah","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.etap.2023.104343_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.clpt.6100377","article-title":"Pharmacokinetic Studies in Pregnant Women","volume":"83","author":"Anger","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.etap.2023.104343_bib5","series-title":"valeurs limites d\u2032exposition professionnelle et valeurs biologiques. (saisines 2018-SA-0150 et 2019-SA-0051)","first-page":"18","article-title":"Avis compl\u00e9t\u00e9 de l\u2032Agence nationale de s\u00e9curit\u00e9 de l\u2032alimentation, de l\u2032environnement et du travail relatif aux valeurs de r\u00e9f\u00e9rence du valproate de sodium (CAS n\u00b01069 66-5) - Valeurs toxicologiques de r\u00e9f\u00e9rence par voie orale et inhalation","author":"Anses","year":"2022"},{"key":"10.1016\/j.etap.2023.104343_bib6","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s00204-016-1910-9","article-title":"Hair analysis for the biomonitoring of pesticide exposure: comparison with blood and urine in a rat model","volume":"91","author":"Appenzeller","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.etap.2023.104343_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2020.151227","article-title":"Pharmacokinetic studies in pregnancy","volume":"44","author":"Avram","year":"2020","journal-title":"Semin Perinatol."},{"key":"10.1016\/j.etap.2023.104343_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-017-0160-x","article-title":"Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally","volume":"8","author":"Barrett","year":"2017","journal-title":"Mol. Autism"},{"key":"10.1016\/j.etap.2023.104343_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1600-0404.1992.tb05485.x","article-title":"Intrauterine growth in the offspring of epileptic mothers","volume":"86","author":"Battino","year":"1992","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.etap.2023.104343_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0272-0590(88)90112-1","article-title":"Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats","volume":"11","author":"Binkerd","year":"1988","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.etap.2023.104343_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1051\/medsci\/2019036","article-title":"[The valproate model of autism]","volume":"35","author":"Bossu","year":"2019","journal-title":"Med Sci. (Paris)"},{"key":"10.1016\/j.etap.2023.104343_bib12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/dmd.106.014456","article-title":"Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways","volume":"35","author":"Cerveny","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.etap.2023.104343_bib13","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.etap.2023.104343_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0006-2952(90)90560-8","article-title":"Early changes in hepatic redox homeostasis following treatment with a single dose of valproic acid","volume":"40","author":"Cotariu","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.etap.2023.104343_bib15","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.psyneuen.2013.06.008","article-title":"The three-hit concept of vulnerability and resilience: toward understanding adaptation to early-life adversity outcome","volume":"38","author":"Daskalakis","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.etap.2023.104343_bib16","doi-asserted-by":"crossref","DOI":"10.4161\/23273747.2014.976123","article-title":"Autistic-like traits in Lewis rats exposed perinatally to a mixture of common endocrine disruptors","volume":"2","author":"Degroote","year":"2014","journal-title":"Endocr. Disruptors"},{"key":"10.1016\/j.etap.2023.104343_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28911-y","article-title":"Exposure to Polycyclic Aromatic Hydrocarbons Leads to Non-monotonic Modulation of DNA and RNA (hydroxy)methylation in a Rat Model","volume":"8","author":"Duca","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.etap.2023.104343_bib18","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1021\/acs.est.6b01059","article-title":"Stereoselective Metabolism of \u03b1-, \u03b2-, and \u03b3-Hexabromocyclododecanes (HBCDs) by Human Liver Microsomes and CYP3A4","volume":"50","author":"Erratico","year":"2016","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.etap.2023.104343_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2013.00088","article-title":"General developmental health in the VPA-rat model of autism","volume":"7","author":"Favre","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.etap.2023.104343_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.657171","article-title":"N6-Methyladenine in Eukaryotic DNA: Tissue Distribution, Early Embryo Development, and Neuronal Toxicity","volume":"12","author":"Fernandes","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.etap.2023.104343_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/abbi.1998.0742","article-title":"P450-catalyzed in-chain desaturation of valproic acid: isoform selectivity and mechanism of formation of Delta 3-valproic acid generated by baculovirus-expressed CYP3A1","volume":"356","author":"Fisher","year":"1998","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.etap.2023.104343_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tox.2005.10.019","article-title":"Subacute effects of the brominated flame retardants hexabromocyclododecane and tetrabromobisphenol A on hepatic cytochrome P450 levels in rats","volume":"218","author":"Germer","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.etap.2023.104343_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.etap.2023.104343_bib24","first-page":"19","article-title":"Epigenetic and neurological impairments associated with early life exposure to persistent organic pollutants","volume":"2019","author":"Grova","year":"2019","journal-title":"Int. J. Genom."},{"key":"10.1016\/j.etap.2023.104343_bib25","unstructured":"Herman, T.F., Santos, C., 2022. First Pass Effect, StatPearls. StatPearls Publishing."},{"key":"10.1016\/j.etap.2023.104343_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108103","article-title":"The epigenetic hallmark of early-life \u03b1-hexabromocyclododecane exposure: From cerebellar 6-mA levels to locomotor performance in adulthood","volume":"178","author":"Holuka","year":"2023","journal-title":"Environ. Int."},{"key":"10.1016\/j.etap.2023.104343_bib27","first-page":"1","article-title":"Analysis of Alternative - HBCDD for use in EPS in Building Applications","author":"INEOS","year":"2011","journal-title":"ECHA"},{"key":"10.1016\/j.etap.2023.104343_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","article-title":"Antiepileptic Drug Interactions - Principles and Clinical Implications","volume":"8","author":"Johannessen","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.etap.2023.104343_bib29","first-page":"277","article-title":"Environmental Chemical Exposures and Autism Spectrum Disorders: A Review of the Epidemiological Evidence","volume":"44","author":"Kalkbrenner","year":"2014","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"10.1016\/j.etap.2023.104343_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","article-title":"Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1\/*1 genotype","volume":"94","author":"Kiang","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.etap.2023.104343_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague\u2013Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.etap.2023.104343_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.etap.2023.104343_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/157488406775268183","article-title":"Pharmacokinetics and Metabolic Drug Interactions","volume":"1","author":"Leucuta","year":"2006","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2023.104343_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3565(25)31137-7","article-title":"Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse","volume":"204","author":"L\u00f6scher","year":"1978","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.etap.2023.104343_bib35","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1021\/acs.chemrestox.0c00076","article-title":"Binding and Metabolism of Brominated Flame Retardant \u03b2-1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane in Human Microsomal P450 Enzymes: Insights from Computational Studies","volume":"33","author":"Ma","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.etap.2023.104343_bib36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.etap.2023.104343_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ntt.2015.08.005","article-title":"Short-term effects of a perinatal exposure to the HBCDD alpha-isomer in rats: Assessment of early motor and sensory development, spontaneous locomotor activity and anxiety in pups","volume":"52","author":"Maurice","year":"2015","journal-title":"Neurotoxicol Teratol."},{"key":"10.1016\/j.etap.2023.104343_bib38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/toxics10040180","article-title":"Head-to-Head Study of Developmental Neurotoxicity and Resultant Phenotype in Rats: \u03b1-Hexabromocyclododecane versus Valproic Acid, a Recognized Model of Reference for Autism Spectrum Disorders","volume":"10","author":"Morel","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.etap.2023.104343_bib39","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0272-0590(86)90179-X","article-title":"Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen","volume":"6","author":"Nau","year":"1986","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.etap.2023.104343_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.etap.2023.104343_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.etap.2023.104343_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0090-9556(25)08733-1","article-title":"The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes","volume":"17","author":"Porubek","year":"1989","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.etap.2023.104343_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2","article-title":"Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei","volume":"370","author":"Rodier","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.etap.2023.104343_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism \u2014 A current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicology Teratol."},{"key":"10.1016\/j.etap.2023.104343_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.reprotox.2009.06.011","article-title":"Developmental toxicity of brominated flame retardants, tetrabromobisphenol A and 1,2,5,6,9,10-hexabromocyclododecane, in rat offspring after maternal exposure from mid-gestation through lactation","volume":"28","author":"Saegusa","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.etap.2023.104343_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08498","article-title":"Modulatory effects of Benjakul extract on rat hepatic cytochrome P450 enzymes","volume":"7","author":"Samuhasaneeto","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.etap.2023.104343_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.taap.2009.06.019","article-title":"Modulation of benzo[a]pyrene induced immunotoxicity in mice actively immunized with a B[a]P-diphtheria toxoid conjugate","volume":"240","author":"Schellenberger","year":"2009","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.etap.2023.104343_bib48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.placenta.2021.07.299","article-title":"Characterizing the effects of in utero valproic acid exposure on murine fetoplacental development","volume":"112","author":"Shafique","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.etap.2023.104343_bib49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/ejhpharm-2020-002367","article-title":"Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy","volume":"29","author":"Song","year":"2022","journal-title":"Eur. J. Hosp. Pharm."},{"key":"10.1016\/j.etap.2023.104343_bib50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2165\/00003088-199325040-00005","article-title":"Individual variation in first-pass metabolism","volume":"25","author":"Tam","year":"1993","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.etap.2023.104343_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2018.12.024","article-title":"Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder","volume":"159","author":"Tartaglione","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.etap.2023.104343_bib52","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.3390\/molecules26123720","article-title":"Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid","volume":"26","author":"Thornton","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.etap.2023.104343_bib53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/epi.12109","article-title":"Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications","volume":"54","author":"Tomson","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.etap.2023.104343_bib54","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kfi185","article-title":"Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes","volume":"86","author":"Tong","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.etap.2023.104343_bib55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.0306-5251.2001.01474.x","article-title":"In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9)","volume":"52","author":"Wen","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.etap.2023.104343_bib56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10571-009-9438-7","article-title":"Ascorbic acid reverses valproic acid-induced inhibition of hoxa2 and maintains glutathione homeostasis in mouse embryos in culture","volume":"30","author":"Zhang","year":"2010","journal-title":"Cell Mol. Neurobiol."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668923002855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668923002855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:56:39Z","timestamp":1761299799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668923002855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":56,"alternative-id":["S1382668923002855"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2023.104343","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic characterisation of a valproate Autism Spectrum Disorder rat model in a context of co-exposure to \u03b1-Hexabromocyclododecane","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2023.104343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104343"}}